PortfoliosLab logoPortfoliosLab logo
MEDX vs. BBH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

MEDX vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Horizon Kinetics Medical ETF (MEDX) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MEDX vs. BBH - Yearly Performance Comparison


2026 (YTD)202520242023
MEDX
Horizon Kinetics Medical ETF
1.52%28.62%-4.68%-6.22%
BBH
VanEck Vectors Biotech ETF
0.04%21.18%-4.29%-1.01%

Returns By Period

In the year-to-date period, MEDX achieves a 1.52% return, which is significantly higher than BBH's 0.04% return.


MEDX

1D
1.19%
1M
-3.98%
YTD
1.52%
6M
8.07%
1Y
27.44%
3Y*
6.83%
5Y*
10Y*

BBH

1D
0.70%
1M
-3.58%
YTD
0.04%
6M
10.55%
1Y
23.57%
3Y*
5.92%
5Y*
1.84%
10Y*
6.42%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MEDX vs. BBH - Expense Ratio Comparison

MEDX has a 0.85% expense ratio, which is higher than BBH's 0.35% expense ratio.


Return for Risk

MEDX vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDX
MEDX Risk / Return Rank: 6868
Overall Rank
MEDX Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
MEDX Sortino Ratio Rank: 7171
Sortino Ratio Rank
MEDX Omega Ratio Rank: 6161
Omega Ratio Rank
MEDX Calmar Ratio Rank: 7474
Calmar Ratio Rank
MEDX Martin Ratio Rank: 6363
Martin Ratio Rank

BBH
BBH Risk / Return Rank: 5858
Overall Rank
BBH Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
BBH Sortino Ratio Rank: 5757
Sortino Ratio Rank
BBH Omega Ratio Rank: 5050
Omega Ratio Rank
BBH Calmar Ratio Rank: 7373
Calmar Ratio Rank
BBH Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDX vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Horizon Kinetics Medical ETF (MEDX) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDXBBHDifference

Sharpe ratio

Return per unit of total volatility

1.30

1.05

+0.25

Sortino ratio

Return per unit of downside risk

1.87

1.53

+0.34

Omega ratio

Gain probability vs. loss probability

1.24

1.20

+0.04

Calmar ratio

Return relative to maximum drawdown

2.15

2.00

+0.15

Martin ratio

Return relative to average drawdown

6.85

5.56

+1.29

MEDX vs. BBH - Sharpe Ratio Comparison

The current MEDX Sharpe Ratio is 1.30, which is comparable to the BBH Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of MEDX and BBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MEDXBBHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.30

1.05

+0.25

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.09

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

0.27

+0.02

Correlation

The correlation between MEDX and BBH is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

MEDX vs. BBH - Dividend Comparison

MEDX's dividend yield for the trailing twelve months is around 1.21%, more than BBH's 0.51% yield.


TTM20252024202320222021202020192018201720162015
MEDX
Horizon Kinetics Medical ETF
1.21%1.23%1.92%4.94%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BBH
VanEck Vectors Biotech ETF
0.51%0.51%0.80%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%

Drawdowns

MEDX vs. BBH - Drawdown Comparison

The maximum MEDX drawdown since its inception was -23.10%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for MEDX and BBH.


Loading graphics...

Drawdown Indicators


MEDXBBHDifference

Max Drawdown

Largest peak-to-trough decline

-23.10%

-72.70%

+49.60%

Max Drawdown (1Y)

Largest decline over 1 year

-10.86%

-10.47%

-0.39%

Max Drawdown (5Y)

Largest decline over 5 years

-39.86%

Max Drawdown (10Y)

Largest decline over 10 years

-39.86%

Current Drawdown

Current decline from peak

-4.91%

-12.15%

+7.24%

Average Drawdown

Average peak-to-trough decline

-6.72%

-26.05%

+19.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.40%

3.76%

-0.36%

Volatility

MEDX vs. BBH - Volatility Comparison

The current volatility for Horizon Kinetics Medical ETF (MEDX) is 6.14%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 7.01%. This indicates that MEDX experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MEDXBBHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.14%

7.01%

-0.87%

Volatility (6M)

Calculated over the trailing 6-month period

13.42%

13.69%

-0.27%

Volatility (1Y)

Calculated over the trailing 1-year period

21.48%

22.72%

-1.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.92%

21.47%

-4.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.92%

22.27%

-5.35%